|
ZC3H14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.01247956871975E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.90947258005281E-12 |
| Normal-vs-Stage2 |
1.424150E-04 |
| Normal-vs-Stage3 |
3.62179999999768E-05 |
| Normal-vs-Stage4 |
2.435400E-03 |
| Stage1-vs-Stage2 |
8.309000E-01 |
| Stage1-vs-Stage3 |
3.669200E-01 |
| Stage1-vs-Stage4 |
9.537600E-01 |
| Stage2-vs-Stage3 |
6.395200E-01 |
| Stage2-vs-Stage4 |
9.307600E-01 |
| Stage3-vs-Stage4 |
6.234000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77702297321503E-12 |
| Normal-vs-AfricanAmerican |
7.48590001098393E-09 |
| Normal-vs-Asian |
1.696510E-03 |
| Caucasian-vs-AfricanAmerican |
5.687400E-01 |
| Caucasian-vs-Asian |
5.528800E-01 |
| AfricanAmerican-vs-Asian |
7.135000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58761892521397E-14 |
| Normal-vs-Female |
5.355000E-04 |
| Male-vs-Female |
3.782800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.18919999695322E-08 |
| Normal-vs-Extreme_Weight |
1.73194791841524E-14 |
| Normal-vs-Obese |
1.99100000042307E-07 |
| Normal-vs-Extreme_Obese |
1.94169999967464E-07 |
| Normal_Weight-vs-Extreme_Weight |
2.656000E-01 |
| Normal_Weight-vs-Obese |
4.475000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.088200E-01 |
| Extreme_Weight-vs-Obese |
3.289900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.215400E-01 |
| Obese-vs-Extreme_Obese |
3.401200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.122400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.50219997446999E-09 |
| Normal-vs-Age(61-80Yrs) |
1.62558855265615E-12 |
| Normal-vs-Age(81-100Yrs) |
9.74869995840066E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.977000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.384400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.495800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.457200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.071780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.070600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.21644966006352E-14 |
| Normal-VS-Type2 PRCC |
9.48630063390965E-11 |
| Normal-VS-KIRP CIMP |
1.765950E-01 |
| Normal-VS-Unclassified PRCC |
2.433900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.658600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.179400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.169600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.733800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.479600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.794200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.78852546293274E-13 |
| Normal-vs-N1 |
4.412300E-02 |
| Normal-vs-N2 |
4.3160999996239E-08 |
| N0-vs-N1 |
7.303400E-03 |
| N0-vs-N2 |
2.763800E-02 |
| N1-vs-N2 |
1.336110E-02 |
|
|
